Baxter International Inc. (BAX) Financials
Key financial figures for Baxter International Inc. (Q3 2026).
Baxter Q3 2026 sales rose 5% to $2.98B, adjusted EPS of $0.58 beat the FMP estimate but fell 16% year over year, and the company raised its full-year outlook. Sales were $2,976M, up 5% on both a reported and organic basis, with growth in all segments; Medical Products & Therapies $2,102M (+6%) and Healthcare Systems & Technologies $806M (+4%). GAAP diluted EPS from continuing operations was $0.57 versus $(0.10) a year earlier, helped by a $253M pre-tax gain on early debt extinguishment ($0.38 per share, excluded from adjusted EPS) after a $600M cash tender offer that retired $864M of debt. On the outlook: FY2026: reported sales growth 4% to 5% (previously 3% to 4%); organic sales growth 3% to 4% (previously 2% to 3%); adjusted diluted EPS from continuing operations $2.05 to $2.15 (previously $1.95 to $2.15). Figures are for Q3 2026, as Baxter International reported them.
- Revenue
- $3.0B
- Net Income
- $294M
- EPS
- $0.57
- Total Assets
- $19.4B
- Operating Cash Flow
- $558M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $3.0B | $294M | $0.57 | 7.56% | $448M |
| Q2 FY2026 | $3.0B | $126M | $0.24 | 7.33% | $32M |
| Q1 FY2026 | $2.7B | -$15M | -$0.03 | 2.44% | $76M |
| Q4 FY2025 | $3.0B | -$1.1B | -$2.16 | -24.51% | $444M |
| Q3 FY2025 | $2.8B | -$46M | -$0.09 | 6.07% | $126M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $11.2B | -$957M | -$1.87 | -2.74% | $323M |
| FY2024 | $10.6B | -$649M | -$1.27 | 0.13% | $559M |
| FY2023 | $10.4B | $2.7B | $5.23 | 6.82% | $1.3B |
Frequently asked questions
What was Baxter International's revenue last quarter?
Baxter International reported revenue of $2.98 billion for Q3 FY2026, up 5.0% from the same period a year earlier.
Is Baxter International profitable?
Yes. Baxter International reported net income of $294.0 million for Q3 FY2026, a net margin of 9.88% on revenue.
How has Baxter International's margin trended?
Operating margin was 7.56% in Q3 FY2026, compared with 6.07% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Baxter International generate?
Baxter International generated free cash flow of $448.0 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Baxter International Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.